Improving diabetes care coordination in the emergency department
Diabetes Electronic Prompt for Improved Care Coordination and Treatment (DEPICCT) in the ED
This study is testing if using alerts in the emergency department can help doctors provide better care for patients with Type 2 Diabetes by getting them treated faster and ensuring they get follow-up care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Trial ID | NCT06899191 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to enhance the management of Type 2 Diabetes (T2D) in the emergency department (ED) by implementing electronic decision support prompts within the electronic health record (EHR). The study will assess whether alerts triggered by high glucose levels and elevated hemoglobin A1c (HA1c) can lead to earlier treatments and improved follow-up care for patients. ED clinicians will receive alerts that suggest additional testing and care coordination based on specific glucose and HA1c thresholds. The outcomes will be compared before and after the intervention to evaluate its effectiveness.
Who should consider this trial
Good fit: Ideal candidates for this study are patients presenting to the ED with moderate hyperglycemia (glucose ≥250 mg/dL) who are not pregnant or recently infected with SARS-COV-2.
Not a fit: Patients experiencing diabetic ketoacidosis, hyperglycemic hyperosmolar state, or those with severe complications like diabetic foot ulcers will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management of diabetes in emergency settings, resulting in improved patient outcomes and reduced complications.
How similar studies have performed: While the use of electronic prompts in clinical settings is gaining traction, this specific approach to diabetes management in the ED is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Moderate hyperglycemia, (glucose ≥250 mg/dL) * Patients who arrive in the emergency department * Not pregnant or peri-partum * Not SARS-COV-2 PCR positive in past 7 days Exclusion Criteria: * Diabetic ketoacidosis (pH \< 7.20, HCO3 \< 15, AG \> 25) * Diabetic foot ulcer or skin complications * Hyperglycemic hyperosmolar state with neurologic impairment * Patients who leave against medical advice (AMA), elope from the ED, or are transferred to another facility
Where this trial is running
New Brunswick, New Jersey
- Rutgers, Robert Wood Johnson Hospital — New Brunswick, New Jersey, United States (Recruiting)
Study contacts
- Study coordinator: Paul Peng, MD PhD MS
- Email: paul.peng@rutgers.edu
- Phone: 732-633-1402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.